✦ LIBER ✦

A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial: Enoxaparin Versus Unfractionated Heparin in Non–ST-Segment Elevation Acute Coronary Syndromes

✍ Scribed by Marc Cohen; Kenneth W. Mahaffey; Karen Pieper; Charles V. Pollack Jr; Elliott M. Antman; James Hoekstra; Shaun G. Goodman; Anatoly Langer; Jacques J. Col; Harvey D. White; Robert M. Califf; James J. Ferguson

Book ID: 119266158
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 156 KB
Volume: 48
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2006.05.058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A perspective on trials comparing enoxap

A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non–ST-elevation acute coronary syndromes

✍ Robert M. Califf; John L. Petersen; Vic Hasselblad; Kenneth W. Mahaffey; James J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Enoxaparin versus tinzaparin in non–ST-s

Enoxaparin versus tinzaparin in non–ST-segment elevation acute coronary syndromes: Results of the enoxaparin versus tinzaparin (EVET) trial at 6 months

✍ Christos Katsouras; Lampros K. Michalis; Nikos Papamichael; Kostas Adamides; Kat 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 237 KB

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED H

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): THE PHARMACOECONOMIC EVALUATION IN RUSSIA

✍ A Syrov; S Zyryanov; YB Belousov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Enoxaparin vs. unfractionated heparin in

Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and Efficacy of Enoxaparin vs Unf

Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and AspirinA Randomized Controlled Trial

✍ Blazing, Michael A. 📂 Article 📅 2004 🏛 American Medical Association 🌐 English ⚖ 180 KB

Randomized double-blind safety study of

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study

✍ Marc Cohen; Pierre Théroux; Steven Borzak; Martin J. Frey; Harvey D. White; W. V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB